Poietis Competitors and Similar CompaniesClear all
Poietis's competitors and similar companies include BFG Group, Keyi Tech, AAI Canada and BioLoomics.
 BFG Group BFG Group is an engineering company developing an intelligent platform for creating digital twin production systems. |  AAI Canada AAI Canada, Inc. (also known as Applied AI Systems) is a company engaged in the development and distribution of mobile robots and artificial intelligence systems. |  BioLoomics BioLoomics is a preclinical-stage biotechnology company leveraging the directed evolution of antibodies in human cells to create target-degrading antibodies. | |||
Founding Date | Founding Date 2014 | Founding Date 2010 | Founding Date 2014 | Founding Date 1983 | Founding Date 2019 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Pessac, FR HQ | Locations HQ | Locations Beijing, CN HQ San Francisco, US | Locations Ottawa, CA HQ | Locations Boulder, US HQ |
Employees | Employees 176% decrease | Employees N/A | Employees 336% increase | Employees 6 | Employees 1616% decrease |
Funding | |||||
Latest funding round | Latest funding round $ 6.2m (about 8 years ago) | Latest funding round $ 3m (almost 7 years ago) | Latest funding round $ 25k (over 11 years ago) | Latest funding round N/A | Latest funding round $ 8.7m (over 2 years ago) |
Total funding raised | Total funding raised $ 8.9m | Total funding raised $ 3m | Total funding raised $ 25k | Total funding raised N/A | Total funding raised $ 19.5m |
For sources of this data, please see the company profile
View Company Profiles
BFG Group
HQ
BFG Group is an engineering company developing an intelligent platform for creating digital twin production systems.
View companyAAI Canada
HQ
Ottawa, CA
Employees
6
AAI Canada, Inc. (also known as Applied AI Systems) is a company engaged in the development and distribution of mobile robots and artificial intelligence systems.
View companyBioLoomics
HQ
Boulder, US
Employees
16↓ 16% decrease
BioLoomics is a preclinical-stage biotechnology company leveraging the directed evolution of antibodies in human cells to create target-degrading antibodies.
View company